|
Notice of Convocation of the General Meeting of Shareholders
2010.02.26
|
|---|
|
Notice of Convocation of the 26th Annual General Meeting of Shareholders
In accordance with Article 25, Paragraph 2 of the Articles of Incorporation, the 26th Annual General Meeting of Shareholders will be convened as follows.
1. Date and Time: March 12, 2010 (Friday), 9:00 a.m.
2. Venue: Main Conference Room, Hyangnam Pharmaceutical Industrial Complex, 900-1 Sangsin-ri, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
3. Agenda Items Reports:
Audit Report
Business Report
Matters for Resolution:
Agenda Item No. 1: Approval of Balance Sheet, Income Statement, and Statement of Appropriation of Retained Earnings (Proposed)
Agenda Item No. 2: Partial Amendment to the Articles of Incorporation
Agenda Item No. 3: Appointment of Outside Director
Agenda Item No. 4: Approval of Director Remuneration Limit
Agenda Item No. 5: Approval of Auditor Remuneration Limit
4. Exercise of Voting Rights by Beneficial Shareholders Pursuant to Article 314, Paragraph 5 of the Financial Investment Services and Capital Markets Act, the Korea Securities Depository (KSD) is not authorized to exercise voting rights on behalf of the shareholders at this general meeting. Therefore, shareholders do not need to submit any statements of intention regarding the exercise of voting rights to the KSD. As before, shareholders may exercise their voting rights directly by attending the meeting in person, or indirectly by submitting a proxy.
February 26, 2010 1062-4, Namhyeon-dong, Gwanak-gu, Seoul Daehan New Pharm Co., Ltd. Chief Executive Officer: Bae Gun-woo (Seal omitted) |


Home